HealthEquity, Inc. — Form 10-Q Summary
Business context and reporting period
Unaudited results cover the three and nine months ended October 31, 2014, compared with the same periods in 2013. HealthEquity provides technology-enabled health savings and spending account services; revenue is primarily from account, custodial, and payment-card fees. It completed its IPO on August 5, 2014.
Financial and operating performance
| Metric | Q3 2014 | Q3 2013 | Nine months 2014 | Nine months 2013 |
|---|---|---|---|---|
| Revenue | $21.9 million | $15.2 million | $63.0 million | $44.9 million |
| Gross profit / margin | $12.2 million / 56% | $8.4 million / 55% | $35.5 million / 56% | $24.4 million / 54% |
| Operating income / margin | $4.3 million / 20% | $3.4 million / 22% | $14.9 million / 24% | $9.9 million / 22% |
| Net income | $3.0 million | $2.0 million | $8.8 million | $6.0 million |
| Adjusted EBITDA (non-GAAP) | $6.1 million | $4.6 million | $19.7 million | $13.0 million |
- Quarterly revenue rose 43%; nine-month revenue rose 40%. Account fees increased 48% and 47%, respectively, as HSA membership grew.
- At October 31, HSA members totaled 1.11 million, up 46% year over year. Assets under management were $1.84 billion, up 41%.
- Cash and equivalents were $107.9 million, versus $13.9 million at January 31, 2014. Total liabilities were $12.2 million; the balance sheet reports no borrowings or notes payable. Stockholders’ equity was $140.5 million.
- Nine-month operating cash flow was $10.6 million, down from $12.4 million. Investing cash outflow was $6.6 million, including $4.9 million for software and capitalized development. Financing provided $90.0 million, chiefly reflecting $132.6 million of net IPO proceeds and $50.3 million in dividends.
Material changes and unusual items
- The IPO issued 10.465 million shares at $14 per share and generated approximately $132.6 million net proceeds. Preferred stock converted into common stock; the company also paid a previously declared $50.0 million common-stock dividend.
- Custodial revenue grew, but average cash yield declined to 1.52% in the quarter from 1.64% and to 1.51% for nine months from 1.65%, partly due to lower-rate bank agreements. Card revenue growth reflected more members and increased card use.
- Operating expenses increased 59% in the quarter and 43% for nine months, including higher technology investment and public-company, personnel, and professional costs. Quarterly operating margin declined from 22% to 20%.
- The filing identifies a prior-quarter error in calculating a stock-option tax benefit: prepaid expenses and additional paid-in capital increased by about $1.0 million, with an equal reclassification between operating and financing cash flows. Management said it was not material; the July 2014 statements were to be revised in a later filing.
Outlook, risks, and controls
- No specific revenue or earnings guidance is provided. Management expects gross margin to remain relatively steady near term, while sales and marketing, technology and development, and general and administrative costs are expected to rise in dollars. Capital spending is expected to remain elevated through the fiscal year to upgrade the platform. Management said cash should cover operating and capital needs for at least 12 months.
- Key risks include dependence on HSA-related tax treatment and healthcare regulation; interest rates and custodial-bank relationships; reliance on a single payment-card BIN sponsor and third-party processors; cybersecurity, fraud, and service continuity; competition; and execution of platform upgrades and rapid growth.
- Disclosure controls were not effective as of October 31, 2014 because of an identified material weakness in accounting for complex, non-routine transactions. Remediation actions were underway but had not operated long enough to establish effectiveness. The filing reports no litigation expected to have a material adverse effect.
Important facts for investors to verify
- Whether the material weakness has been fully remediated and whether subsequent filings report further accounting corrections.
- Whether member, AUM, and card-use growth can sustain revenue while custodial yields remain under pressure.
- Whether technology upgrades, capital spending, and rising operating costs affect future margins and cash generation.
- The status and terms of the payment-card sponsor and custodial-bank relationships, including the disclosed sponsor consent order.
- The January 2015 expiration of IPO-related lock-ups and potential share sales; the filing notes substantial restricted shares and registration rights.